{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:48:25Z","timestamp":1790340505357,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.jneuroim.2009.02.004","type":"journal-article","created":{"date-parts":[[2009,3,11]],"date-time":"2009-03-11T04:40:22Z","timestamp":1236746422000},"page":"120-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Association of HLA-A in autoimmune myasthenia gravis with thymoma"],"prefix":"10.1016","volume":"210","author":[{"given":"Claire","family":"Vandiedonck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Raffoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Eymard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Tranchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Dulmet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Krumeich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gajdos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri-Jean","family":"Garchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2009.02.004_bib1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1196\/annals.1254.055","article-title":"Myasthenia gravis in individuals over 40","volume":"998","author":"Aarli","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02115001","article-title":"Different HLA DR-DQ associations in subgroups of idiopathic myasthenia gravis","volume":"31","author":"Carlsson","year":"1990","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jneuroim.2009.02.004_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000236508","article-title":"HLA and Singaporean Chinese myasthenia gravis","volume":"101","author":"Chan","year":"1993","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cncr.10665","article-title":"New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China","volume":"95","author":"Chen","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jneuroim.2009.02.004_bib5","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib6","first-page":"921","article-title":"Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population","volume":"12","author":"Excoffier","year":"1995","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.1.5899.131","article-title":"Myasthenia gravis, autoantibodies, and HL-A antigens","volume":"1","author":"Feltkamp","year":"1974","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1468-1331.2003.00686.x","article-title":"HLA class II genotypes in Mexican Mestizo patients with myasthenia gravis","volume":"10","author":"Garcia-Ramos","year":"2003","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib9","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.57.9.1555","article-title":"Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies","volume":"57","author":"Giraud","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2009.02.004_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0165-5728(96)00008-2","article-title":"Polymorphic amino acid domains of the HLA-DQ molecule are associated with disease heterogeneity in myasthenia gravis","volume":"65","author":"Hjelmstrom","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nrg1489","article-title":"Gene map of the extended human MHC","volume":"5","author":"Horton","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib12","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0002-9440(10)64426-4","article-title":"Chromosome 6 suffers frequent and multiple aberrations in thymoma","volume":"161","author":"Inoue","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib13","first-page":"3708","article-title":"Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas","volume":"63","author":"Inoue","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni1581","article-title":"Up on the tightrope: natural killer cell activation and inhibition","volume":"9","author":"Lanier","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib14","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/ijc.20946","article-title":"Nasopharyngeal carcinoma-susceptibility locus is localized to a 132\u00a0kb segment containing HLA-A using high-resolution microsatellite mapping","volume":"115","author":"Lu","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jneuroim.2009.02.004_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/clim.1999.4710","article-title":"Correlation of thymic pathology with HLA in myasthenia gravis","volume":"91","author":"Machens","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1010612327647","article-title":"Brain glioma and human leukocyte antigens (HLA)\u2014is there an association","volume":"52","author":"Machulla","year":"2001","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib17","first-page":"129","article-title":"Paraneoplastic autoimmunity in thymus tumors","volume":"6","author":"Marx","year":"1998","journal-title":"Dev. Immunol."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib18","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1172\/JCI32377","article-title":"HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection","volume":"117","author":"McAulay","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2249.2003.02113.x","article-title":"Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and\/or myasthenia gravis","volume":"132","author":"Meager","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/cncr.10226","article-title":"The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients","volume":"94","author":"Okumura","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jneuroim.2009.02.004_bib20","series-title":"Histological Typing of Tumours of the Thymus","author":"Rosai","year":"1999"},{"key":"10.1016\/j.jneuroim.2009.02.004_bib21","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2249.2007.03442.x","article-title":"Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas","volume":"149","author":"Scarpino","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1399-0039.1991.tb01851.x","article-title":"Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations","volume":"37","author":"Spurkland","year":"1991","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jneuroim.2009.02.004_bib23","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1073\/pnas.88.14.5989","article-title":"Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2","volume":"88","author":"Storkus","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib24","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/ana.20340","article-title":"Selective loss of regulatory T cells in thymomas","volume":"56","author":"Strobel","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/path.2141","article-title":"Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1)","volume":"211","author":"Strobel","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib26","doi-asserted-by":"crossref","first-page":"15464","DOI":"10.1073\/pnas.0406756101","article-title":"Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia","volume":"101","author":"Vandiedonck","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl","key":"10.1016\/j.jneuroim.2009.02.004_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaut.2005.09.010","article-title":"Genetics of autoimmune myasthenia gravis: the multifaceted contribution of the HLA complex","volume":"25","author":"Vandiedonck","year":"2005","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2009.02.004_bib28","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"Vincent","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2009.02.004_bib29","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archneur.58.6.885","article-title":"Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients","volume":"58","author":"Yamamoto","year":"2001","journal-title":"Arch. Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572809000642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572809000642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:11:01Z","timestamp":1759047061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572809000642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0165572809000642"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2009.02.004","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of HLA-A in autoimmune myasthenia gravis with thymoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2009.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}